Literature DB >> 30324387

Precision and reliability of liver iodine quantification from spectral detector CT: evidence from phantom and patient data.

Nils Große Hokamp1,2,3, Nuran Abdullayev4, Thorsten Persigehl4, Max Schlaak5, Christian Wybranski4, Jasmin A Holz4, Thomas Streichert6, Hatem Alkadhi7, David Maintz4, Stefan Haneder4.   

Abstract

OBJECTIVE: To comprehensively assess precision, reproducibility, and repeatability of iodine maps from spectral detector CT (SDCT) in a phantom and in patients with repetitive examination of the abdomen.
METHODS: Seventy-seven patients who underwent examination two (n = 52) or three (n = 25) times according to clinical indications were included in this IRB-approved, retrospective study. The anthropomorphic liver phantom and all patients were scanned with a standardized protocol (SSDE in patients 15.8 mGy). In patients, i.v. contrast was administered and portal venous images were acquired using bolus-tracking technique. The phantom was scanned three times at three time points; in one acquisition, image reconstruction was repeated three times. Region of interest (ROI) were placed automatically (phantom) or manually (patients) in the liver parenchyma (mimic) and the portal vein; attenuation in conventional images (CI [HU]) and iodine map concentrations (IM [mg/ml]) were recorded. The coefficient of variation (CV [%]) was used to compare between repetitive acquisitions. If present, additional ROI were placed in cysts (n = 29) and hemangioma (n = 29).
RESULTS: Differences throughout all phantom examinations were < 2%. In patients, differences between two examinations were higher (CV for CI/IM: portal vein, 2.5%/3.2%; liver parenchyma, -0.5%/-3.0% for CI/IM). In 80% of patients, these differences were within a ± 20% limit. Differences in benign liver lesions were even higher (68% and 38%, for CI and IM, respectively).
CONCLUSIONS: Iodine maps from SDCT allow for reliable quantification of iodine content in phantoms; while in patients, rather large differences between repetitive examinations are likely due to differences in biological distribution. This underlines the need for careful clinical interpretation and further protocol optimization. KEY POINTS: • Spectral detector computed tomography allows for reliable quantification of iodine in phantoms. • In patients, the offset between repetitive examinations varies by 20%, likely due to differences in biological distribution. • Clinically, iodine maps should be interpreted with caution and should take the intra-individual variability of iodine distribution over time into account.

Entities:  

Keywords:  Contrast media; Liver; Phantoms, imaging; Reproducibility of results; Tomography, X-ray computed

Mesh:

Substances:

Year:  2018        PMID: 30324387     DOI: 10.1007/s00330-018-5744-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  4 in total

1.  Inter-scan and inter-scanner variation of quantitative dual-energy CT: evaluation with three different scanner types.

Authors:  Simon Lennartz; Anushri Parakh; Jinjin Cao; David Zopfs; Nils Große Hokamp; Avinash Kambadakone
Journal:  Eur Radiol       Date:  2021-01-14       Impact factor: 5.315

2.  Renal cystic lesions characterization using spectral detector CT (SDCT): Added value of spectral results.

Authors:  Rivka Kessner; Nils Große Hokamp; Les Ciancibello; Nikhil Ramaiya; Karin A Herrmann
Journal:  Br J Radiol       Date:  2019-05-24       Impact factor: 3.039

3.  Quantitative accuracy of virtual non-contrast images derived from spectral detector computed tomography: an abdominal phantom study.

Authors:  Jasmin A Holz; Hatem Alkadhi; Kai R Laukamp; Simon Lennartz; Carola Heneweer; Michael Püsken; Thorsten Persigehl; David Maintz; Nils Große Hokamp
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

4.  Value of spectral detector computed tomography for the early assessment of technique efficacy after microwave ablation of hepatocellular carcinoma.

Authors:  Robert Peter Reimer; Nils Große Hokamp; Julius Niehoff; David Zopfs; Simon Lennartz; Mariam Heidar; Roger Wahba; Dirk Stippel; David Maintz; Daniel Pinto Dos Santos; Christian Wybranski
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.